Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 10, 2021 08:30 ET | Source: VectivBio AG

VectivBio Announces Third Quarter 2021 Business Update

-Pivotal STARS Program of Apraglutide in SBS-IF Progressing with Majority of Sites Activated and Screening; STARS Nutrition Interim Results Expected 1H 2022- -Expanded Rare Disease Pipeline with...
September 03, 2021 07:15 ET | Source: VectivBio AG

VectivBio Announces Results of Extraordinary General Meeting

BASEL, Switzerland, Sept. 03, 2021 (GLOBE NEWSWIRE) -- VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for...
August 31, 2021 07:00 ET | Source: VectivBio AG

VectivBio to Acquire Comet Therapeutics and Host R&D Day

- Acquisition of Innovative Small Molecule Platform Significantly Expands Rare Disease Pipeline -- VectivBio to Host R&D Day on September 21, 2021- BASEL, Switzerland, Aug. 31, 2021 (GLOBE...